title: [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Pro].
authors.affiliation: Arbeitsbereich Psychosen, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Deutschland. lambert@uke.de.
authors.forename: M
authors.initials: M
authors.lastname: Lambert
authors.affiliation: Recognition and Prevention Program, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
authors.forename: C
authors.initials: C
authors.lastname: Correll
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006801:Humans; D062706:Prodromal Symptoms; D011618:Psychotic Disorders / Q000209:etiology* / Q000517:prevention & control* / Q000523:psychology; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents